Minerva Surgical Q3 EPS $(0.81) Beats $(1.00) Estimate, Sales $11.96M Miss $13.21M Estimate
Minerva Surgical Q3 EPS $(0.81) Beats $(1.00) Estimate, Sales $11.96M Miss $13.21M Estimate
Minerva Surgical 第三季度每股收益（0.81 美元）超過美元（1.00）的預期，銷售額爲1196萬美元，未達到1321萬美元的預期
Minerva Surgical (NASDAQ:UTRS) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.00) by 19 percent. This is a 89.88 percent increase over losses of $(8.00) per share from the same period last year. The company reported quarterly sales of $11.96 million which missed the analyst consensus estimate of $13.21 million by 9.42 percent. This is a 4.95 percent decrease over sales of $12.59 million the same period last year.
Minerva Surgical（納斯達克股票代碼：UTRS）公佈季度每股虧損0.81美元（0.81美元），比分析師普遍估計的1.00美元（1.00）高出19％。這比去年同期每股虧損89.88美元（8.00美元）增加了89.88％。該公司公佈的季度銷售額爲1,996萬美元，比分析師共識估計的1,321萬美元低9.42％。這比去年同期的1,259萬美元的銷售額下降了4.95％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。